AFC-HD AMS Life Science Co

AFC-HD AMS Life Science Co EBIT per Employee

The EBIT per Employee of AFC-HD AMS Life Science Co (2927.T) as of Nov 4, 2026 is 2.79 M JPY. In the previous year, EBIT per Employee was 2.71 M JPY — a change of 2.82% (higher).

EBIT per Employee

2.79 MJPY

YoY

2.82%

Last updated:

EBIT per Employee of AFC-HD AMS Life Science Co is 2026 2.79 M JPY. EBIT per Employee of AFC-HD AMS Life Science Co was 2025 2.71 M JPY. It decreases by 2.82% higher compared to the previous year.

The AFC-HD AMS Life Science Co EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
1.12 M JPY
Jan 1, 2020
1.25 M JPY
Jan 1, 2021
2.56 M JPY
Jan 1, 2022
1.16 M JPY
Jan 1, 2023
1.86 M JPY
Jan 1, 2024
2.18 M JPY
Jan 1, 2025
2.71 M JPY
Jan 1, 2026
2.79 M JPY
The AFC-HD AMS Life Science Co EBIT per Employee history
YEAREBIT per EmployeeYoY
2.79 MJPY+2.82%
2.71 MJPY+24.21%
2.18 MJPY+17.11%
1.86 MJPY+61.21%
1.16 MJPY-54.79%
2.56 MJPY+105.29%
1.25 MJPY+11.46%
1.12 MJPY-4.12%
1.17 MJPY-4.28%
1.22 MJPY+20.03%
1.01 MJPY-6.35%
1.08 MJPY+68.49%
642,969.25JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AFC-HD AMS Life Science Co Stock analysis

What does AFC-HD AMS Life Science Co do? AFC-HD AMS Life Science Co., Ltd. generates revenue through its Healthcare segment, which produces and sells health foods, cosmetics, and OEM services for other brands. The Pharmaceutical segment manufactures and sells ethical drugs, over-the-counter drugs, and generic medicines. The company also manages restaurants via a subsidiary, contributing to its diversified income streams. Customers include businesses seeking OEM partnerships and consumers purchasing health and pharmaceutical products. The firm's products are sold under its own brand and through OEM agreements, targeting both individual consumers and corporate clients. The Healthcare segment focuses on wellness products, while the Pharmaceutical segment caters to medical needs with prescription and non-prescription drugs. The restaurant management subsidiary provides additional revenue from food service operations. Revenue is derived from the sale of health foods, cosmetics, Chinese medicine medicines, general medicines, and healthcare products within the Healthcare segment. The Pharmaceutical segment's income comes from ethical drugs, over-the-counter drugs, and generic medicines. The restaurant subsidiary's operations further support the company's financial structure through food service sales. AFC-HD AMS Life Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AFC-HD AMS Life Science Co stock

EBIT per Employee of AFC-HD AMS Life Science Co is 2.79 M JPY in 2026.

EBIT per Employee of AFC-HD AMS Life Science Co changed from 2.71 M JPY to 2.79 M JPY, representing a 2.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee AFC-HD AMS Life Science Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's AFC-HD AMS Life Science Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — AFC-HD AMS Life Science Co

All Key Metrics — AFC-HD AMS Life Science Co